325 related articles for article (PubMed ID: 26238606)
1. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
Malm H; Sourander A; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Artama M; Brown AS
Am J Psychiatry; 2015 Dec; 172(12):1224-32. PubMed ID: 26238606
[TBL] [Abstract][Full Text] [Related]
2. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
5. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
Malm H; Artama M; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague I; Sourander A
BMC Psychiatry; 2012 Dec; 12():217. PubMed ID: 23206294
[TBL] [Abstract][Full Text] [Related]
6. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
[TBL] [Abstract][Full Text] [Related]
7. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Grzeskowiak LE; Gilbert AL; Morrison JL
J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
[TBL] [Abstract][Full Text] [Related]
8. SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden.
Skalkidou A; Sundström-Poromaa I; Wikman A; Hesselman S; Wikström AK; Elenis E
BJOG; 2020 Oct; 127(11):1366-1373. PubMed ID: 32162458
[TBL] [Abstract][Full Text] [Related]
9. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
10. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
11. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.
Yonkers KA; Gilstad-Hayden K; Forray A; Lipkind HS
JAMA Psychiatry; 2017 Nov; 74(11):1145-1152. PubMed ID: 28903165
[TBL] [Abstract][Full Text] [Related]
12. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
Malm H; Klaukka T; Neuvonen PJ
Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
[TBL] [Abstract][Full Text] [Related]
13. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
Ames JL; Ladd-Acosta C; Fallin MD; Qian Y; Schieve LA; DiGuiseppi C; Lee LC; Kasten EP; Zhou G; Pinto-Martin J; Howerton EM; Eaton CL; Croen LA
Biol Psychiatry; 2021 Aug; 90(4):253-262. PubMed ID: 34116791
[TBL] [Abstract][Full Text] [Related]
14. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
Upadhyaya S; Brown A; Cheslack-Postava K; Gissler M; Gyllenberg D; Heinonen E; Laitinen J; McKeague I; Hinkka-Yli-Salomäki S; Sourander A; Tornio A; Malm H
Reprod Toxicol; 2023 Jun; 118():108365. PubMed ID: 36958464
[TBL] [Abstract][Full Text] [Related]
15. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
[TBL] [Abstract][Full Text] [Related]
16. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
17. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period.
Hwang YM; Roper RT; Piekos SN; Enquobahrie DA; Hebert MF; Paquette AG; Baloni P; Price ND; Hood L; Hadlock JJ
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2313364. PubMed ID: 38342572
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Lund N; Pedersen LH; Henriksen TB
Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
[TBL] [Abstract][Full Text] [Related]
19. Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.
Johansen RL; Mortensen LH; Andersen AM; Hansen AV; Strandberg-Larsen K
Paediatr Perinat Epidemiol; 2015 Jan; 29(1):72-81. PubMed ID: 25382157
[TBL] [Abstract][Full Text] [Related]
20. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
Chen X; Gissler M; Lavebratt C
Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
